Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lone Larsen

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Inflammatory Bowel Diseases|December 10, 2024
Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With BiologicsMirabella Zhao, Lene Buhl Riis, Bobby Lo, et al.
Acta Oncologica (Stockholm, Sweden)|October 11, 2021
A national study on the inter-observer variability in the delineation of organs at risk in the brainEbbe Laugaard Lorenzen, Jesper Folsted Kallehauge, Camilla Skinnerup Byskov, et al.
Gastroenterology|February 10, 2026
Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course SeverityMarie Vibeke Vestergaard, Kristine Højgaard Allin, Anne Krogh Nøhr, et al.
Journal of Crohn'S & Colitis|May 18, 2025
Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel diseaseArno R Bourgonje, Susanne Ibing, Alexandra E Livanos, et al.
Eclinicalmedicine|March 11, 2022
Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trialMarianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, et al.
Scandinavian Journal of Gastroenterology|March 24, 2025
Temporal trends in characteristics and management of inflammatory bowel diseaseJessica C Young, Lise M Helsingen, Erle Refsum, et al.
Alimentary Pharmacology & Therapeutics|September 2, 2021
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort studyMette Julsgaard, Daniel C Baumgart, Simon M D Baunwall, et al.
Inflammatory Bowel Diseases|March 24, 2022
Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based StudyMohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, et al.
Journal of Crohn'S & Colitis|November 10, 2021
Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level DataMohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2019
Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel diseaseSteffen Bank, Mette Julsgaard, Osama Karim Abed, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Inflammatory Bowel Diseases|December 10, 2024
Histological, But Neither Clinical Nor Endoscopic Activity Predicts the Risk of Colectomy in Patients With Ulcerative Colitis Treated With BiologicsMirabella Zhao, Lene Buhl Riis, Bobby Lo, et al.
Acta Oncologica (Stockholm, Sweden)|October 11, 2021
A national study on the inter-observer variability in the delineation of organs at risk in the brainEbbe Laugaard Lorenzen, Jesper Folsted Kallehauge, Camilla Skinnerup Byskov, et al.
Gastroenterology|February 10, 2026
Genetic Risk of Inflammatory Bowel Disease Is Associated With Disease Course SeverityMarie Vibeke Vestergaard, Kristine Højgaard Allin, Anne Krogh Nøhr, et al.
Journal of Crohn'S & Colitis|May 18, 2025
Distinct perturbances in metabolic pathways associate with disease progression in inflammatory bowel diseaseArno R Bourgonje, Susanne Ibing, Alexandra E Livanos, et al.
Eclinicalmedicine|March 11, 2022
Low-dose azathioprine and allopurinol versus azathioprine monotherapy in patients with ulcerative colitis (AAUC): An investigator-initiated, open, multicenter, parallel-arm, randomised controlled trialMarianne Kiszka-Kanowitz, Klaus Theede, Sandra Bohn Thomsen, et al.
Scandinavian Journal of Gastroenterology|March 24, 2025
Temporal trends in characteristics and management of inflammatory bowel diseaseJessica C Young, Lise M Helsingen, Erle Refsum, et al.
Alimentary Pharmacology & Therapeutics|September 2, 2021
Vedolizumab clearance in neonates, susceptibility to infections and developmental milestones: a prospective multicentre population-based cohort studyMette Julsgaard, Daniel C Baumgart, Simon M D Baunwall, et al.
Inflammatory Bowel Diseases|March 24, 2022
Association Between the Clinical, Biochemical, and Endoscopic Activity of Inflammatory Bowel Diseases and Severity and Long-term Outcomes of Coronavirus Disease 2019-A Population-based StudyMohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, et al.
Journal of Crohn'S & Colitis|November 10, 2021
Outcomes and Long-Term Effects of COVID-19 in Patients with Inflammatory Bowel Diseases - A Danish Prospective Population-Based Cohort Study with Individual-Level DataMohamed Attauabi, Jens Frederik Dahlerup, Anja Poulsen, et al.
Alimentary Pharmacology & Therapeutics|February 28, 2019
Polymorphisms in the NFkB, TNF-alpha, IL-1beta, and IL-18 pathways are associated with response to anti-TNF therapy in Danish patients with inflammatory bowel diseaseSteffen Bank, Mette Julsgaard, Osama Karim Abed, et al.
Pageof 6